Chambers Michael Andrew

Insider profile

Performance

Overall performance
2.9

Performance over holding periods
2.9
30 days 90 days 120 days
Average return 5% 8.2% 15.1%
Success rate 79% 68% 82%
Transactions
14 100% Buy
34 71% Buy
47 69% Buy
Chambers Michael Andrew's trades of Sarepta Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-08-20 2024-08-16 B Purchase
87,621 -49.1%
361.60
US$2,388,549
87,621 -49.1% 361.60 US$2,388,549
2024-08-20 2024-08-16 B Purchase
28,283 +25.6%
87.01
US$2,115,104
28,283 +25.6% 87.01 US$2,115,104
2024-08-20 2024-08-16 B Purchase
29,926 +49.8%
264.28
US$4,239,992
29,926 +49.8% 264.28 US$4,239,992
2023-08-15 2023-08-14 B Purchase
4,032 +1.7%
109.89
US$443,076
4,032 +1.7% 109.89 US$443,076
2023-08-15 2023-08-14 B Purchase
5,947 +2.5%
109.19
US$649,353
5,947 +2.5% 109.19 US$649,353
2023-08-14 2023-08-11 B Purchase
23,686 +11.1%
108.05
US$2,559,272
23,686 +11.1% 108.05 US$2,559,272
2023-08-11 2023-08-10 B Purchase
31,570 +17.4%
106.26
US$3,354,628
31,570 +17.4% 106.26 US$3,354,628
2023-08-11 2023-08-10 B Purchase
1,091 +0.6%
105.90
US$115,537
1,091 +0.6% 105.90 US$115,537
2023-08-11 2023-08-10 B Purchase
2,206 +1.2%
104.67
US$230,902
2,206 +1.2% 104.67 US$230,902
2022-09-15 2022-09-14 B Purchase
6,250 +6.1%
105.16
US$657,250
6,250 +6.1% 105.16 US$657,250
2022-09-15 2022-09-14 B Purchase
30,106 +41.9%
104.67
US$3,151,195
30,106 +41.9% 104.67 US$3,151,195
2022-09-15 2022-09-14 B Purchase
20,744 +40.6%
103.87
US$2,154,679
20,744 +40.6% 103.87 US$2,154,679
2022-08-22 2022-08-19 B Purchase
6,060 +13.5%
108.80
US$659,328
6,060 +13.5% 108.80 US$659,328
2022-08-22 2022-08-19 B Purchase
40,110 +817.2%
108.20
US$4,339,902
40,110 +817.2% 108.20 US$4,339,902